Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Glaxo Lotronex Studies May Expand Market To Men, Teens, Pediatrics

Feb 14 2000

• By The Pink Sheet

Related Content

Glaxo SmithKline Taking Soft Merger Route: Will Start With Two U.S. Heads

Feb 07 2000

Detrol Sales Potential Could Be $1 Bil. With Once-Daily Indication, P&U Says

Feb 14 2000

Glaxo Lotronex Indication Would Cover One-Third Of IBS Patients

Nov 22 1999

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window